Mitochondrial donation study for parents of confirmed mtDNA mutation
Part of Hormones & metabolism clinical trials.
This study follows families using mitochondrial donation to reduce the risk from a confirmed mitochondrial DNA (mtDNA) mutation. It aims to learn outcomes over about 18 months of the child’s life and whether the treatment works well and safely for families like yours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with a confirmed mitochondrial DNA (mtDNA) mutation
- Your clinical team says you can receive mitochondrial donation under UK fertility law
- You have agreed to join the study before mitochondrial donation begins
- You can follow the study visit schedule and required check-ins
- You agree to share pregnancy, birth, and baby information through 18 months of age
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to learn more about mitochondrial DNA diseases by building a group of people with these conditions. The information gathered may help doctors give better genetic counseling to families.
This study follows people with mitochondrial disease over time to learn more about how the condition progresses. It may help researchers find better ways to manage and treat mitochondrial diseases in the future.
This trial builds a large database and collection of lab results, and possibly tissue samples, from people with suspected or diagnosed mitochondrial conditions. It helps researchers learn more about these disorders and mitochondrial DNA changes, which may improve future diagnosis and treatments.
This study looks for the cause of suspected mitochondrial diseases by combining multiple lab tests on muscle and skin samples, plus genetic testing results. If your current gene tests didn’t find an answer, this could help researchers learn what might be causing your condition.
This trial tests a one-time infusion of your own blood cells mixed with donated mitochondria to see if it can help children with Pearson Syndrome grow better and improve their health. It is a new approach that aims to provide the energy your cells need.
This Phase 2 trial tests a treatment made from deoxynucleosides to help people with mitochondrial depletion disorder caused by certain gene changes. If you match the genetic diagnosis, the study may see whether the treatment improves symptoms or disease markers.
Hear when a new Mitochondrial Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.